A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2019
Price : $35 *
At a glance
- Drugs Vinflunine (Primary)
- Indications Penile cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms VinCaP
- 08 Feb 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 05 Jun 2018 Primary endpoint (Clinical benefit rate (CBR) after 4 cycles of vinflunine) has been met, according to results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2018 Status changed from active, no longer recruiting to completed, according to results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.